Search

everythinglearnresearchcommunity

for

Search:↓

The COVID-19 pandemic has caused a 57% increase in interest in facial cosmetic procedures, leading to calls for better industry regulation and professional standards.

Post-COVID syndrome causes long-lasting symptoms like fatigue, breathing issues, and anxiety.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

Blood type affects COVID-19 infection rates differently in Europe and Africa.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.

A woman with ectopic Cushing's syndrome and COVID-19 passed away despite treatment.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Anabolic steroid users may face higher risk of severe COVID-19.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

There's no significant genetic link between male pattern baldness and COVID-19.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

COVID-19 can cause rashes and worsen existing skin conditions, and behaviors like frequent hand-washing can lead to hand dermatitis.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

A new teledermatology system improved access and reduced wait times for skin care.

No significant link between male pattern baldness and COVID-19 severity was found.

Covid-19 affected asthmatic patients in Western Saudi Arabia.

COVID-19 affects patients on chemotherapy for gynecological cancer negatively.

Testosterone may influence COVID-19 severity and outcomes.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.